Patent · US Active

Factor VIII polymer conjugates

US8071724B2 · kind B2 · utility

1Cited by

27References

2Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Peter Turecek · Klosterneuburg, AT
Juergen Siekmann · Wien, AT

Key dates

Filing date	Jan 20, 2011
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Jan 20, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.